Abstract
Angiotensin II (AngII) is the major regulator of blood pressure, electrolyte balance, and some endocrine functions related to cardiovascular diseases. Moreover, it has been shown that AngII plays a role in various pathological situations involving tissue remodelling and in cancer. Two distinct subtypes of AngII receptors [type 1 (AT1) and type 2 (AT2)] have been identified, and both belong to the G protein-coupled receptor (GPCR) superfamily. A knowledge of the 3D structure of AT receptors could be of great help in the task of understanding molecular interactions, and in the rational design of specific ligands; however, as GPCRs are membrane-bound proteins, high-resolution structural characterization is still an extremely difficult task. For this reason, great importance has been placed on molecular modelling studies and in particular, on homology modelling (HM) techniques. In this review, we report and analyze the main experimental data and the computational procedures and validation methods used for the construction of the AT receptors, describing in details the most successful results and new trends.
Keywords: Angiotensin receptors, AT1, AT2, homology modelling, GPCR
Current Medicinal Chemistry
Title: Computational Approaches on Angiotensin Receptors and Their Ligands: Recent Developments and Results
Volume: 14 Issue: 29
Author(s): Tiziano Tuccinardi and Adriano Martinelli
Affiliation:
Keywords: Angiotensin receptors, AT1, AT2, homology modelling, GPCR
Abstract: Angiotensin II (AngII) is the major regulator of blood pressure, electrolyte balance, and some endocrine functions related to cardiovascular diseases. Moreover, it has been shown that AngII plays a role in various pathological situations involving tissue remodelling and in cancer. Two distinct subtypes of AngII receptors [type 1 (AT1) and type 2 (AT2)] have been identified, and both belong to the G protein-coupled receptor (GPCR) superfamily. A knowledge of the 3D structure of AT receptors could be of great help in the task of understanding molecular interactions, and in the rational design of specific ligands; however, as GPCRs are membrane-bound proteins, high-resolution structural characterization is still an extremely difficult task. For this reason, great importance has been placed on molecular modelling studies and in particular, on homology modelling (HM) techniques. In this review, we report and analyze the main experimental data and the computational procedures and validation methods used for the construction of the AT receptors, describing in details the most successful results and new trends.
Export Options
About this article
Cite this article as:
Tuccinardi Tiziano and Martinelli Adriano, Computational Approaches on Angiotensin Receptors and Their Ligands: Recent Developments and Results, Current Medicinal Chemistry 2007; 14 (29) . https://dx.doi.org/10.2174/092986707782793970
DOI https://dx.doi.org/10.2174/092986707782793970 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
G Protein β γ Subunits as Targets for Small Molecule Therapeutic Development
Combinatorial Chemistry & High Throughput Screening Hypertension and Concurrent Arrhythmias
Current Pharmaceutical Design Editorial (New Wave from Immunology, Endocrine & Metabolic Agents in Medicinal Chemistr )
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Obstructive Sleep Apnea Syndrome: From Phenotype to Genetic Basis
Current Genomics The Significance of Renal Function in Response to Cardiac Resynchronisation Therapy – A Piece of a Much Larger Puzzle
Current Vascular Pharmacology What Have We Learned from the Novel Human Cytochromes P450 Hidden in the Databases?
Current Genomics The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance
Current Clinical Pharmacology Strategies to Tackle Early Low Flow States in the Extremely Preterm Infant
Current Pediatric Reviews Platelet Function and Antiplatelet Therapy in Cardiovascular Disease: Implications of Genetic Polymorphisms
Current Vascular Pharmacology Increased Risk of Dementia in Patients with Non-Apnea Sleep Disorder
Current Alzheimer Research The Fabry Cardiomyopathy - Diagnostic Approach and Current Treatment
Current Pharmaceutical Design Cardiovascular Aspect of Beta-Thalassaemia
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Amino Acids in the Modulation of Cardiac Metabolism During Ischemia and Heart Failure
Current Pharmaceutical Design Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond
Current Medicinal Chemistry Anti-Oxidative Effect of Curcumin Against Tert-Butylhydroperoxide Induced Oxidative Stress in Human Erythrocytes
The Natural Products Journal Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
Current Cardiology Reviews Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life Data from Boceprevir or Telaprevir based “Triple Therapy” Experience in Southern Italy
Reviews on Recent Clinical Trials Bioactive Molecules from the <i>Alpinia</i> Genus: A Comprehensive Review
Current Pharmaceutical Biotechnology Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Surgical Correction of Hyperopia, Myopia and Presbyopia Review of Recent Ophthalmological Patents
Recent Patents on Biomedical Engineering (Discontinued)